Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Neoplasm, Residual × Letrozole × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Ovarian Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm, Residual 1 Estrogen Receptor-positive Breast Cancer 1 Endometrial Endometrioid Adenocarcinoma 1 Brain Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

venetoclax 1 palbociclib 1 fludarabine 1 asparaginase erwinia chrysanthemi recombinant 1 Zymosan 1 Letrozole 1 Idarubicin 1 Etoposide 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04130152 2022-10-25

PROMETEO II

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡